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Chlamydia trachomatis (CT) is the leading cause of diseases related to reproductive health and iron plays important role in
chlamydial pathogenesis. Iron homeostasis in chlamydia-infected cells is not clear thus far. This study shows that expression of the
transferrinreceptor(TfR)isdownregulated,whereasexpressionoftheferritinheavychainisupregulatedinCT-infectedHeLa-229
cells. Expression of iron-regulatory protein (IRP)-1 predominates over IRP-2 in infected cells. In infected cells, attenuated binding
activity ofIRP-ironresponsive elements (IREs)is observed using the electrophoretic mobility-shift assay. These results suggest that
iron homeostasis is modulated in CT-infected HeLa cells at the interface of acquisition and commensal use of iron.
Copyright © 2009 Harsh Vardhan et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Chlamydiatrachomatis(CT)isoneofthemostsuccessfuland
leading bacterial pathogens that cause sexually transmitted
infections; it infects and grows within the genital mucosal
epithelial cells [1]. Chlamydial infection is responsible
for pelvic inﬂammatory disease, tubal infertility, ectopic
pregnancy, and endometritis, having signiﬁcant impact on
the reproductive health of women worldwide [2]. The
developmental cycle of CT includes two forms: an infectious
elementary body (EB) and a reticulate body that multiplies
within the inclusion by binary ﬁssion [3]. A third devel-
opmental form—the persistent form and is considered as
a mechanism of survival under stressful conditions [4, 5].
Persistence is induced in response to changes in the culture
medium, including amino acid or iron deprivation and in
the presence of antibiotics or cytokines such as gamma
interferon (IFN-γ)[ 6–10].
Iron is the most essential element because of its role
in the chemistry related to bioenergetics, being involved
in a myriad of biochemical events that are required for
growth and development [11]. Excess iron promotes the
generation of reactive radicals, which channelize pathogenic
cascades that damage cells and tissues. Iron, as an essential
nutrient and potential toxin, poses an exquisite regulatory
problem in biological systems [12]. Iron homeostasis of
cells is regulated posttranscriptionally by the binding of
iron-regulatoryproteins(IRP)-1and-2withiron-responsive
elements (IREs). In iron-starved cells, binding of IRP to IRE
stabilizes the transferrin-receptor (TfR) mRNA and inhibits
the translation of mRNAs that encode the heavy (H) and
light (L) chains of ferritin, thus promoting cellular iron
uptake and preventing iron sequestration [13].
Almost all cells and organisms exploit iron as a cofactor
in a multitude of biochemical activities. CT EBs harvested
fromdesferal-exposedpolarizedepithelialcellshasareduced
infective potential, which is restored after replacement with
iron-saturated transferrin medium, thus conﬁrming the
dependence of chlamydia on the host for its requirement of
iron [14]. Chlamydial genomic annotation provides an idea
about the iron-transporter analog of ExbB/D; however, an
identiﬁable TonB is absent [15]. The CT divalent cation-
dependent regulator is a distant relative of the ferric-uptake
regulator family of iron-responsive regulators [16]. The
biphasic life cycle of chlamydia provides various oppor-
tunities for cross-communication with the host regulatory2 Journal of Biomedicine and Biotechnology
network. No study is available currently regarding the
involvement of chlamydiae in the regulation of intracellular
iron in infected HeLa cells. This study aims to provide a
clue to the chlamydial modulatory eﬀect on host cells at the
interface of acquisition and commensal use of iron.
2.MaterialsandMethods
Unlessotherwisestated,allthereagentswerepurchasedfrom
Sigma Aldrich (Saint Louis, Mo, USA) and antibodies, from
Santa Cruz Biotechnology (Santa Cruz, Calif, USA). Plastic
wares and glasswares for tissue culture were obtained from
Greiner, Germany.
2.1. Culture of CT. CT, laboratory reference serovar D
(D/UW-3/Cx), propagated in HeLa-229 cells as described
previously [17], were puriﬁed and stored at −80◦Ci n
sucrose-phosphate-glutamate medium (pH 7.0). The inoc-
ula were conﬁrmed to be free from contamination with
Mycoplasma spp. using speciﬁc kits (Mycoplasma detection
kit, Takara, Madison, USA).
2.2. Infection Protocol. HeLa-229 (1 × 106 cells/well) cells
were seeded in 6-well tissue-culture plates (Greiner, Ger-
many). Subsequently, the HeLa cell monolayer was washed
with Hank’s balanced salt solution (HBSS) and inoculated
with chlamydial EBs at a multiplicity of infection (moi)
of 2. Next, the tissue-culture plates were placed on a
rocker (Bangalore Genei Pvt. Ltd, Bangalore, India) for
2 hours at 35◦C to obtain a homogeneous infectivity.
The infected monolayer was washed twice with HBSS and
supplemented with complete Dulbecco’s modiﬁed eagle
medium containing 10% fetal calf serum. Infected HeLa
cells were incubated at 37◦Cw i t h5 %C O 2 in a humid
environment. Deferoxamine (DFX) and ferric ammonium
citrate (FAC) were added after 16 hours postinfection (hpi)
in the respective wells; after 24 hpi, the cells were withdrawn
for analysis. All the experiments were carried out in triplicate
with mock-infected cells as their respective controls.
2.3. Cytosolic Extract Preparation. Infected (2 × 106)c e l l s
were lysed with 140μLo fl y s i sb u ﬀer (20mM N-2-
hydroxyethylpiperazine-N
 -2-ethanesulfonic acid (HEPES),
25mM KCl, 0.5% NP-40, and 1mM DTT) for 10 minutes
on ice. Subsequently, the lysates were centrifuged (Platocraft,
Rota 4R-V, Mumbai, India) at 15,000 × gf o r1 5m i n u t e sa t
4◦Ctoremovethecelldebrisandnucleus.Proteinconcentra-
tionsweredeterminedbytheBradfordproteinassay(BioRad
Laboratories,USA),withbovineserumalbumin(BSA)asthe
standard.
2.4. Electrophoretic Mobility-Shift Assay. A radiolabeled
probe of the IRE was transcribed by the in vitro tran-
scription method. The IRE sequence of 5 GAGTTCCGT-
CCAAGCACUTGAAGCAGGAAACTCTCTCCCTATAGT-
GAGTCGTATTA3  was used as the template, and the T7
sequence 5 TATAGTGAGTCGTATTA3  as the primer for
the ampliﬁcation step carried out using an in vitro tran-
scription kit (Roche Applied Science, Penzberg, Germany).
T h ep r o b ew a st r e a t e dw i t hR N a s e - f r e eD N a s eIt or e m o v e
DNA contamination and subsequently extracted by the
phenol-chloroform (1 : 1, v/v) method. The cytoplasmic
extract (20μg) was mixed with 10ng of [32P] CTP-labeled
IRE in binding buﬀer (10mM HEPES, pH 7.6, 40mM
KCl, 3mM MgCl2, and 5% glycerol) and incubated at
room temperature for 20 minutes. After incubation, the
complex was resolved on a 6% nondenaturing acrylamide
gel. In a parallel experiment, samples were treated with
2-mercaptoethanol (2-ME) at a ﬁnal concentration of 2%
before addition of the IRE probe, to allow the complete
expression of IRE-binding activity. Amersham phospho-
screen was exposed to the gels for autoradiography and
scanned using a PhosphorImager (Typhoon 9700, Amer-
sham, Uppasala, Sweden). Band-shift experiments were
carried out at least three times, and one representative
experiment is shown.
2.5. Immunoblotting of Proteins. CT-infected HeLa cells
were washed with phosphate buﬀered saline (PBS) and
subsequently treated with lysis buﬀer (0.5% Nonidet P-
40, 150mM NaCl, 0.1% sodium dodecyl sulfate (SDS),
50mM NaF, 1mM Na3VO4, and 1mM phenyl methyl
sulfonylﬂuoride)containingthecompleteprotease-inhibitor
cocktail (Roche Diagnostics, Mannheim, Germany). Protein
concentrations were determined by the Bradford protein
assay (BioRad Laboratories) with BSA as standard. Extracted
proteins (40μg) were electrophoresed on 8–12% SDS-
polyacrylamide gels and transferred to polyvinyl diﬂuoride
membranes (BioRad Laboratories); the membranes were
reversiblystainedwithPonceauS(SigmaAldrich)toconﬁrm
complete transfer. Membranes were blocked with 5% nonfat
dry milk in PBS-Tween-20 and incubated with rabbit anti-
IgGs against TfR-1, ferritin heavy chain (FHC), IRP-1, and
IRP-2; they were further incubated with the goat anti-rabbit
IgG conjugated with horseradish peroxidase. Subsequently,
they were developed using diaminobenzamide as the detec-
tion agent and analyzed using the Image J software.
2.6. Statistical Analysis. Statistical analysis was carried out
with the GraphPad Prism software (version 5.0). Diﬀerences
were tested for statistical signiﬁcance by one-way analysis
of variance, followed by the Bonferroni posttest. Each
experiment was carried out in triplicate.
3. Results
3.1. Expression of TfR in CT-Infected HeLa Cells. As visual-
ized by the Western blot assay, expression of TfR decreased
in CT-infected HeLa cells in comparison to mock-infected
cells. After addition of the intracellular iron chelator DFX,
there was no change in the expression of TfR, whereas
mock infection showed a signiﬁcant increase. However, iron
supplementation with FAC to CT-infected HeLa cells did
not lead to a change in the TfR level, in comparison to the
respective controls (Figure 1(a)).Journal of Biomedicine and Biotechnology 3
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Figure 1: Eﬀect of CT infection on TfR expression in HeLa cells: HeLa cells were infected at 2moi and treated with the iron chelator DFX
mesylate and ferric ammonium citrate (FAC). Mock-infected cells were considered as the control. Treated and untreated cells were harvested
at 24hpi, and the cell lysates (40μg) were electrophoresed on 8–12% SDS-PAGE gel, followed by Western blot analysis using anti-TfR and
anti-FHC antibodies, with beta-actin as the loading control. (a) Expression of the TfR was downregulated in CT-infected HeLa cells and did
not change after addition of DFX and FAC. (b) Expression of FHC was studied in CT-infected HeLa cells in comparison to control. FHC
level remained above the basal level (mock) in CT-infected cells after addition of DFX. Conversely, addition of FAC led to a higher degree of
induction in the FHC level of CT-infected cells than that in the control. Bars represent standard error. ∗P<. 05 and ∗∗P<. 01.
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Figure 2: Eﬀect of CT infection on IRP-1 expression in HeLa cells: 40μg cell lysates were electrophoresed on 8% SDS-PAGE gels, followed
by Western blotting using anti-IRP-1 and anti-IRP-2 antibodies, with beta-actin as control. (a) CT-infected HeLa cells showing higher
expression of IRP-1, which declined after addition of DFX. (b) Decline in the level of IRP-2 expression was observed in CT-infected HeLa
cells, and there was further decline consequent to addition of DFX. No signiﬁcant change was observed in FAC-treated control and infected
cells. Bars represent standard error. ∗P<. 05 and ∗∗∗P<. 001.
3.2. Expression of FHC in CT-Infected HeLa Cells.
Chlamydia-infected HeLa cells showed higher expression of
FHC in comparison to the mock-infected cells. Following
the addition of DFX, FHC expression remained above the
basal (mock) level. Moreover, subsequent to addition of
FAC, upregulation of FHC was observed in both infected
and mock-infected HeLa cells, as visualized by the Western
blot assay (Figure 1(b)).
3.3. Levels of IRP-1 and IRP-2. In chlamydia-infected HeLa
cells, the level of IRP-1 was higher in comparison to mock-
infected cells (Figure 2(a)), whereas IRP-2 did not show
any signiﬁcant diﬀerence (Figure 2(b)). Consequent to the
addition of the intracellular iron chelator DFX, the level of
IRP-1 increased signiﬁcantly, whereas IRP-2 did not show
such change in CT-infected cells in comparison to mock-
infected cells (Figure 2(b)). Addition of iron supplement led4 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of CT infection on the interaction of IRP-IRE: cytoplasmic extracts were prepared from CT-infected HeLa cells treated
with DFX and FAC, along with their respective controls, at 24hpi. Furthermore, the extracts were incubated with 32P-labeled RNA probe,
which contained the IRE sequence, in binding buﬀer. For the supershift assay, the corresponding antibodies (IRP-1 and IRP-2) were added.
In parallel experiments, samples were treated with 2-mercaptoethanol) for determination of the maximum binding activity. (a) Binding
activity of IRP-1/IRE was attenuated in CT-infected HeLa cells as observed in electrophoretic mobility-shift assay. (b) Inhibition of binding
was observed with IRP-1 antibodies in CT-infected HeLa cells. (c) Attenuation of binding activity reverted to normal after treatment with
chloramphenicol.
to signiﬁcant changes in both infected and mock-infected
HeLa cells (Figure 2(a)).
3.4. Attenuated Binding Activity of IRP-1/IRE (RNA Elec-
trophoretic Mobility-Shift Assay). The binding activity was
determined using the electrophoretic mobility-shift assay
by comparison of the maximum activity (2 ME-treated
cytoplasmic extract showed maximum activity) with the
actual observed activity. The cytoplasmic extract of CT-
infected HeLa cells showed a signiﬁcant decrease in the
binding activity relative to mock-infected cells. In the
presence of DFX, increased binding activity was observed
in both the conditions although the signal was relatively
low in CT-infected cells (Figure 3(a)). When the cytosolic
extract was preincubated with anti-IRP1 and anti-IRP2
antibodies,itshowedlossofbindingonlyinthecaseofIRP-1
(Figure 3(b)). Binding activity resumed in CT-infected HeLa
cells after chloramphenicol treatment (Figure 3(c)).
4. Discussion
CT is one of the most successful bacterial pathogen in terms
ofintracellularsurvivalduetoitsabilitytomodulatethehost
resources toward its own development. Both host and the
pathogens have higher aﬃnities for iron, the most essential
element required for survival.
In accordance with previous studies, the current results
showed a decline in the expression of TfR in CT-infected
HeLa cells. In contrast to other intracellular pathogens, CT
showed upregulation of TfR expression [18]. TfR-mediated
iron acquisition has been reported as an important mode
of iron uptake, contributing the major part of the iron
requirement in various cell types [19]. Regulation of TfR
is sensitive to various intracellular physiological conditions;
s e c r e t o r yf a c t o r s ,s u c ha sI F N - γ, tumor necrosis factor-α,
interleukin-1, and interleukin-6, downregulate the TfR level
invariouscelltypes[20].Experimentalmodelsofchlamydial
infection have shown upregulation in the levels of IFN-γ
[21]. Therefore, these results may suggest the involvement of
secretory factors in the downregulation of TfR in chlamydia-
infected cell. Furthermore, the present study showed that
TfR expression did not change signiﬁcantly after addition
of DFX and FAC. This result deciphers the modulation
of the iron-regulatory machinery of cells infected with
CT.
In this study, upregulation of FHC was observed in CT-
infected cells, which did not alter signiﬁcantly after addition
of the iron chelator DFX. Physiological responses reportedJournal of Biomedicine and Biotechnology 5
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Figure 4: Translational initiation of ferritin and TfR mRNA degradation are regulated by binding of IRP to IRE in response to availability of
iron. (1) In the excess iron, IRP forms an open conformation and is not able to bind IRE, subsequently translation of ferritin gets initiated
and degradation of exposed TfR mRNA takes place. (2) In iron starved cells, IRP attains a closed conformation and binds to IRE present on
5  UTR of ferritin mRNA thus interferes with translation initiation and simultaneously stabilize TfR mRNA by binding 3  UTR. (3) Binding
aﬃnity of IRP-IRE is attenuated in presence of chlamydia leading to lower expression of TfR and higher expression of FHC [27].
for TNF-α, IL-1, IL-6, and IFN-γ include stimulation of H-
ferritin expression and inhibition of TfR1 expression [19].
These results further explain the involvement of cytokines
of the innate immune system in the upregulation of FHC.
However, nonresponsiveness of the CT-infected cells to the
iron chelator DFX might indicate modulation of the iron-
regulatory system.
Chlamydia-infected HeLa cells showed the predominant
expression of IRP-1 rather than IRP-2, in contrast to mock-
infected cells. In iron-depleted condition, IRP-1/2 binding
to IRE blocks ferritin-mRNA translation and simultaneously
stabilizes the TfR mRNA, thus regulating the iron uptake
and storage [22]. Because of the additional 73 amino-acid
peptidesequence,IRP-2ispronetoproteosomaldegradation
in the presence of nitric oxide and iron [23]. Chlamydial
infection induces the production of both nitric oxide and
IFN-γ/α in diﬀerent cell types [24]. In response to the same
stimulus, IRP-1 and -2 are regulated conversely [25]. Hence,
it may suggest that lower levels of IRP-2 might be due to the
proteosomal degradation induced by nitric oxide or converse
regulation by IFN-γ.
In this study, Chlamydia-infected HeLa cells showed
attenuation in IRP-IRE binding activity; however, the bind-
ing activity resumed after addition of chloramphenicol.
Levels of TfR and ferritin are principally regulated through
the binding of IRPs with IREs, and the binding activity of
IRP-IRE is dependent on both the free reactive iron (labile
iron pool) and the intracellular redox state [13]. The labile
iron pool regulates the binding of IRP-1/2 to IREs through
distinct mechanisms. In the presence of high levels of iron,
IRP-1 assembles in a cubane [4Fe-4S] cluster, inhibiting the
IRE-binding activity, and converting IRP-1 to an aconitase.
When cellular iron stress is low, IRP-1 binds to IRE targets as
anapoprotein(seeFigure 4)[26,27].IRPsarealsocontrolled
by other eﬀectors that include reactive oxygen species, which
induce the disassembly of the Fe-S cluster of IRP-1 [28], and
nitric oxide and hypoxia, which aﬀect both IRPs [23].
Serine phosphorylation is an iron-independent mech-
anism of IRP-1 regulation, which destabilizes the Fe-S
cluster [29, 30]. The attenuated binding activity of IRP-1
leads to upregulation of FHC in Chlamydia-infected cells,
in comparison to mock-infected cells, which is inhibited
subsequent to DFX treatment. These results indicate that the6 Journal of Biomedicine and Biotechnology
level of intracellular free iron (Labile Iron Pool) is main-
tained at a critically functional state in chlamydia-infected
cells; however, further study is required to establish this
assumption. Iron restriction-induced chlamydial persistence
is only achieved by DFX and not by exporter-dependent
iron deprivation [31]. In a recent study, Nupur et al. have
shown that Leishmania donovanii uses labile iron pool (LIP)
as a dynamic source of iron inside the cells [32]. These
observations further extend the possible involvement of LIP
as a source of iron for intracellular development of CT.
Hence, this study showed that chlamydial infection has a
modulatory eﬀect on the activity of IRPs which leads to
decreased TfR and increased FHC expressions thus limiting
the intracellular availability of catalytic-free iron and ﬁnally
reactive oxygen species. Furthermore, chlamydial infection
may accelerate the recycling of TfR and transferrin to the
surface, thus recharge the required iron in LIP by faster
shuttling. Transiting iron in LIP may be sequestered in FHC
as stored available iron for CT in HeLa infected cells. Thus,
the current ﬁndings suggest that attenuation in the binding
activityofIRP-1/IREmaybeoneofthemechanismsinvolved
in modulation of iron homeostasis in CT-infected cells.
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